Buscar
Congreso SOLACI
Home Tags TAVR

Tag: TAVR

Cerebral Embolic Protection Devices: How Useful are they in TAVR?

solaci - 0
Endocarditis infecciosa post TAVI

Is TAVR Beneficial in Cardiogenic Shock?

solaci - 0
Impella

Impella in High Risk Coronary Angioplasty before TAVR

solaci - 0
TCT 2023 | ALIGN AR trial

TCT 2023 | EVOLUT Low Risk: 4-Year Follow-up

solaci - 0
TCT 2023 | ALIGN AR trial

TCT 2023 | The WATCH-TAVR Study

solaci - 0
Sedación consciente vs anestesia general en el TAVI

Cause of Cardiac Death after TAVR at Present

solaci - 0
pacemaker marcapasos definitivo

Predictors and Evolution of Need for PPM after TAVR with Self-Expanding...

solaci - 0
Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

TAVR Durability at 5 Years in Intermediate Risk Patients

solaci - 0

Aortic Stenosis and Cardiogenic Shock: Is TAVR an Option?

solaci - 0

VASC-OBSERVANT II Substudy: Impact of Vascular Complications after TAVR

solaci - 0
1...567...51Page 6 of 51

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad